Bioxcel Therapeutics Inc (BTAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,472 | -106,931 | -80,806 | -53,995 | -26,376 |
| Depreciation Amortization | 77 | 297 | 221 | 144 | 65 |
| Other Working Capital | -4,843 | 4,980 | 1,099 | -505 | 1,106 |
| Other Operating Activity | 3,825 | 19,501 | 17,265 | 12,334 | 5,565 |
| Operating Cash Flow | $-32,413 | $-82,153 | $-62,221 | $-42,022 | $-19,640 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -120 | -445 | -433 | -416 | -316 |
| Investing Cash Flow | $-120 | $-445 | $-433 | $-416 | $-316 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 102,447 | 102,447 | 102,376 | 852 |
| Financing Cash Flow | $N/A | $102,447 | $102,447 | $102,376 | $852 |
| Beginning Cash Position | 232,968 | 213,119 | 213,119 | 213,119 | 213,119 |
| End Cash Position | 200,435 | 232,968 | 252,912 | 273,057 | 194,015 |
| Net Cash Flow | $-32,533 | $19,849 | $39,793 | $59,938 | $-19,104 |
| Free Cash Flow | |||||
| Operating Cash Flow | -32,413 | -82,153 | -62,221 | -42,022 | -19,640 |
| Capital Expenditure | -120 | -445 | -433 | -416 | -316 |
| Free Cash Flow | -32,533 | -82,598 | -62,654 | -42,438 | -19,956 |